Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PAICS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HDGF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC31A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDHC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHRM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HGF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EDEM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PWAR6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
DCAF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CENPC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRP72 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2D3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALNT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EMP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on